Enhancement of cellular immune activity

Enhancement of cellular immune activity refers to interventions or processes that increase the activation, proliferation, and effector functions of immune cells, such as T lymphocytes, natural killer (NK) cells, dendritic cells, and macrophages. This is a therapeutic goal in vaccine development, cancer therapy, and immunodeficiency treatment, often achieved via adjuvants or immunostimulatory molecules that increase cytokine production, antigen presentation, or direct cytotoxic activity. Rather than denoting a single molecular target, it encompasses many pathways and cell types involved in mediating robust cell-mediated immune responses.

Other names

Stimulation of cellular immunityAugmentation of cell-mediated immune responseActivation of cellular immune response

Multiple pathways: TLR agonism, cGAS-STING pathway activation, enhancement of cytokine signaling such as IL-12, IFN-γ, TNF-α, and adjuvant-induced APC maturation